Targeting NO/cGMP Signaling in the CNS for Neurodegeneration and Alzheimer's Disease

被引:36
作者
Ben Aissa, Manel [1 ]
Lee, Sue H. [1 ]
Bennett, Brian M. [2 ,3 ]
Thatcher, Gregory R. J. [1 ]
机构
[1] Univ Illinois, Coll Pharm, Dept Med Chem & Pharmacognosy, Chicago, IL 60612 USA
[2] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON, Canada
[3] Queens Univ, Ctr Neurosci Studies, Kingston, ON, Canada
关键词
Alzheimer's disease; CREB activation; NO/cGMP signaling; neuroprotection; synaptic function; LONG-TERM POTENTIATION; NITRIC-OXIDE SYNTHASE; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; SOLUBLE GUANYLATE-CYCLASE; ELEMENT-BINDING PROTEIN; NO-INDEPENDENT STIMULATORS; PDE9 INHIBITOR PF-04447943; NEUROTROPHIC FACTOR LEVELS; MILD COGNITIVE IMPAIRMENT; CAMP-RESPONSIVE ELEMENT;
D O I
10.2174/0929867323666160812145454
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
cAMP-response element-binding protein (CREB) plays a central role in various aspects of central nervous system (CNS) function, ranging from the developmental stages to neuronal plasticity and survival in adult brain. Activation of CREB plays a crucial role in learning and memory and is at the convergence of multiple intracellular signaling cascades including CAMKII and MAPK. This review focuses on the important functions of nitric oxide (NO) in activating CREB via the NO receptor, soluble guanylyl cyclase (sGC), and production of the second messenger, cGMP. The involvement of the NO/cGMP signaling pathway in synaptic plasticity suggests several avenues for therapeutic intervention, and targeting early synaptic degeneration could be an attractive approach for the development of novel disease-modifying approaches to treat cognition and memory dysfunction in neurodegenerative diseases.
引用
收藏
页码:2770 / 2788
页数:19
相关论文
共 249 条
[1]   NO-SSRIs: Nitric Oxide Chimera Drugs Incorporating a Selective Serotonin Reuptake Inhibitor [J].
Abdul-Hay, Samer ;
Schiefer, Isaac T. ;
Chandrasena, R. Esala P. ;
Li, Min ;
Abdelhamid, Ramy ;
Wang, Yue-Ting ;
Tavassoli, Ehsan ;
Michalsen, Bradley ;
Asghodom, Rezene T. ;
Luo, Jia ;
Thatcher, Gregory R. J. .
ACS MEDICINAL CHEMISTRY LETTERS, 2011, 2 (09) :656-661
[2]   NO-flurbiprofen reduces amyloid-β, is neuroprotective in cell culture, and enhances cognition in response to cholinergic blockade [J].
Abdul-Hay, Samer O. ;
Luo, Jia ;
Ashghodom, Rezene T. ;
Thatcher, Gregory R. J. .
JOURNAL OF NEUROCHEMISTRY, 2009, 111 (03) :766-776
[3]  
Adams JP, 2000, ACTA NEUROBIOL EXP, V60, P377, DOI 10.55782/ane-2000-1357
[4]   Rofecoxib in patients with mild cognitive impairment: Further analyses of data from a randomized, double-blind, trial [J].
Aisen, Paul S. ;
Thal, Leon J. ;
Ferris, Steven H. ;
Assaid, Christopher ;
Nessly, Michael L. ;
Giuliani, Michael J. ;
Lines, Christopher R. ;
Norman, Barbara A. ;
Potter, William Z. .
CURRENT ALZHEIMER RESEARCH, 2008, 5 (01) :73-82
[5]   Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression - A randomized controlled trial [J].
Aisen, PS ;
Schafer, KA ;
Grundman, M ;
Pfeiffer, E ;
Sano, M ;
Davis, KL ;
Farlow, MR ;
Jin, S ;
Thomas, RG ;
Thal, LJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (21) :2819-2826
[6]   Nitric oxide deficiency promotes vascular side effects of cyclooxygenase inhibitors [J].
Anning, Peter B. ;
Coles, Barbara ;
Morton, Jonathan ;
Wang, Haibin ;
Uddin, Jashim ;
Morrow, Jason D. ;
Dey, Sudhansu K. ;
Marnett, Lawrence J. ;
O'Donnell, Valerie B. .
BLOOD, 2006, 108 (13) :4059-4062
[7]   In vitro activation of soluble guanylyl cyclase and nitric oxide release: A comparison of NO donors and NO mimetics [J].
Artz, JD ;
Toader, V ;
Zavorin, SI ;
Bennett, BM ;
Thatcher, GRJ .
BIOCHEMISTRY, 2001, 40 (31) :9256-9264
[8]   Endothelial nitric oxide deficiency promotes Alzheimer's disease pathology [J].
Austin, Susan A. ;
Santhanam, Anantha V. ;
Hinton, David J. ;
Choi, Doo-Sup ;
Katusic, Zvonimir S. .
JOURNAL OF NEUROCHEMISTRY, 2013, 127 (05) :691-700
[9]   Synaptic dysfunction in Parkinson's disease [J].
Bagetta, Vincenza ;
Ghiglieri, Veronica ;
Sgobio, Carmelo ;
Calabresi, Paolo ;
Picconi, Barbara .
BIOCHEMICAL SOCIETY TRANSACTIONS, 2010, 38 :493-497
[10]  
Bales KR, 2010, TOP MED CHEM SER, V6, P57, DOI 10.1007/7355_2010_8